Financebotresearch desk研究台

ITW › analyze

ITW · Analyze

WATCH Industrials

Price at analysis: $265.20 | 52-week range: $238.82–$303.16 (-12.5% off high, +11.0% off low) | Mkt cap: $75.53B | EV: $84.38B

Context: sleeve-vacancy nomination for 📈 Income–Yield Tomorrow, listed in Watchlist.md as a routing candidate alongside JNJ/LIN. This is a first-ever file on ITW — no prior report or note exists to carry forward or contradict.

0. Knowledge Check

python .mcp/kb.py find ITW returned no matches — fresh look, nothing to cite. python .mcp/kb.py find industrials surfaced only field-sweep notes (defensive-income-fields, robotics-machine-vision) that don't cover ITW directly, plus the report index — no live note blocks or pre-answers this.

Pitfalls checked before trusting any vendor number:

  • pitfall-vendor-forward-eps-is-the-wrong-fiscal-year — fires. fin.py's PE(fwd) 21.39 divides price by a forwardEps implying ~$12.40/share. But ITW's own FY2026 guidance, raised at the Jul-28-2026 Q2 print, has an EPS midpoint of $11.45 (range not disclosed in the search snippet, but $11.45 is the confirmed midpoint, up $0.15 from the prior guide). $265.20 ÷ $11.45 = 23.16x, not 21.39x — Yahoo's forward field is blending in FY2027 consensus one year too far out, the same pattern found on XYL and PNR. All forward-multiple math below uses the company's own $11.45 FY26 guide, not Yahoo's forward field.
  • pitfall-dyt-inverts-when-price-caused-the-yield — checked, does not fire the same way here. Current yield sits modestly above its 5yr average, but unlike XYL/PNR the price hasn't cratered — ITW is only 12.5% off its 52-week high. The elevated relative yield is dividend-driven (a real 7% raise cadence outpacing the stock's own re-rating), not a post-crash artifact. Treated as a mild, genuine positive signal below.
  • Divestiture-gain distortion in FY2024 net income — no existing pitfall note names this pattern, but it is directly analogous to pitfall-divested-segment-corrupts-multiyear-cagr. FY2024's cash-flow statement shows a $395M divestiture gain (cf_cash_for_divestitures) and a -$591M non-cash adjustment, both absent in FY2025. Diluted EPS fell $11.71 (2024) → $10.49 (2025), a headline -10.4% "decline" — this is a comp/normalization artifact from the one-time 2024 gain, not business deterioration. It also explains most of the payout-ratio jump (48.6% → 58.2%) discussed below. Flagged for the orchestrator as a candidate new pitfall pattern; not written here per scope lock.
  • ITW is a plain US domestic filer (Illinois-incorporated, reports in USD) — none of the ADR/dual-class/FX-translation traps apply.

1. Fundamentals

Free cash flow & the leverage-funded-payout wrinkle

FY Revenue FCF FCF/share (roic.ai) Diluted shares
2022 $15.93B $1.94B — 310.7M
2023 $16.11B $3.08B — 303.6M
2024 $15.90B $2.84B $9.58 297.8M
2025 $16.04B $2.71B $9.29 292.3M

fin.py's headline 11.8% 3yr FCF CAGR is real but flatters the same way PNR's did — 2022 was a depressed base (heavy working-capital build), so most of the "growth" is recovery, not a repeatable rate. The more current signal is the -3.6% FCF/share decline, 2024→2025 (roic.ai, cross-checked against fin.py's $2.84B→$2.71B), which lines up with the organic-growth deceleration StockStory has flagged (see Sentiment) rather than being a one-off.

Only 2 years of roic.ai history are available on the free tier (pitfall-roicai-free-plan-caps-history-at-two-years) — the framework's preferred 5-8yr FCF CAGR isn't fully derivable from the tools on hand; the table above is the full depth fin.py's 4-year statement window provides. Flagged as a genuine data gap, not papered over.

Capital allocation — a real, two-year-running finding

FY FCF Buybacks Dividends Buybacks+Div vs FCF
2025 $2.71B $1.50B $1.79B $3.28B — $0.58B OVER FCF
2024 $2.84B $1.50B $1.70B $3.20B — $0.35B OVER FCF
2023 $3.08B $1.50B $1.61B $3.11B — roughly matched

For two straight years, dividends + buybacks have run ahead of free cash flow, bridged by rising short-term borrowing (bs_st_borrow $1.61B→$2.35B, 2024→2025) — total debt has climbed steadily, $7.95B (2022) → $9.21B (2025). This is not a distress signal — net debt/EBITDA is a comfortable 1.76x and EBITDA/interest coverage is 15.8x (roic.ai FY2025) — but it is a genuine, watchable capital-allocation pattern: ITW is treating its $1.50B/yr buyback program as close to non-negotiable even in a year FCF fell, funding the gap with debt rather than trimming repurchases. Worth flagging as a risk factor, not an alarm.

Debt-to-Assets — headline-scary, structurally explained

fin.py shows D/E 334.85% and Debt/Assets 57.04%, which look like leverage red flags in isolation. The explanation is capital-structure, not distress: ITW's book equity has been mechanically shrunk by 15+ years of buybacks (equity is just $3.23B against $16.15B of assets), so any debt-to-equity ratio on this base reads alarmingly high. The credit-quality numbers that actually matter — net debt/EBITDA 1.76x, EBITDA/interest 15.8x, current ratio 1.11x — say the balance sheet is in normal-to-strong shape for an A-rated industrial. Treat the D/E and Debt/Assets headline figures as a capital-structure artifact, not a leverage risk, but note the trend above (debt is drifting up, not down).

Shares outstanding — genuine, ongoing tailwind

Diluted shares: 310.7M (2022) → 292.3M (2025), a -2.0% 3yr CAGR — real, uninterrupted buyback-driven reduction, the mechanism behind the D/E distortion above and a durable tailwind to per-share value.

Top/bottom-line growth — the StockStory bear case, verified

Revenue CAGR is essentially flat (0.2% 3yr per fin.py), and StockStory's specific numbers check out: 2-year annualized revenue growth of ~1.4%, below ITW's own 5-year trend, and next-12-month consensus growth of ~4.1% is soft for a stock carrying a premium multiple. This sits in tension with the Q2 FY2026 print (organic +4.5%, record $1.15B operating income, GAAP EPS +10% YoY, FY26 guide raised to a 3.5% organic midpoint / $11.45 EPS midpoint) — the trailing multi-year trend is genuinely slow, but the most recent quarter and the raised guide show real re-acceleration. Both things are true; neither should be silently dropped in favor of the other.

Margins — the 80/20 model's clearest evidence

FY2024 FY2025
Gross margin 44.28% 44.10%
Operating margin 26.82% 26.28%
EBITDA margin 29.35% 28.75%
ROIC 29.08% 26.92%

Margins are elite and essentially stable — a ~2-point ROIC and ~0.5-point operating-margin give-up year-over-year, not erosion. This is the direct fingerprint of the 80/20 operating model (decentralized business units, price-based costing, relentless SKU/customer rationalization) doing what it's designed to do.

Per-share metrics

Revenue/share $54.89, FCF/share $9.26–$9.29 (fin.py/roic.ai agree) — both figures are genuine per-owner numbers; buybacks are shrinking the share count, not manufacturing an illusion of growth on flat-to-declining absolute FCF (pattern-buyback-manufactured-eps-screens-as-growth does not apply cleanly here — the buyback is real and share-count-reducing, but it is also debt-assisted per the capital-allocation finding above, which is the more relevant caveat).

2. Dividend-Grower Overlay

  • 63 consecutive years of dividend increases — a Dividend King, among the longest active streaks in US equities (shorter than EMR's 69-year streak already in this sleeve, but comfortably past the 50-year King threshold).
  • Current confirmed quarterly rate in the raw dividend-actions data: $1.61/qtr ($6.44 annualized), last raised Sept-2025 (+7.3% from $1.50). Multiple 2026 news sources describe "a 7% 2026 dividend increase" and a "63rd straight hike" cycle — fin.py's snapshot yield (2.61%) implies a slightly higher trailing dividend (~$6.92) than the raw payment history confirms (~$6.44), a ~7% gap consistent with a just-announced raise (~$1.72-1.73/qtr) not yet reflected in the cached payment-history feed. Flagged as an open reconciliation item rather than asserted as fact — use $6.44/2.43% yield as the conservative, confirmed figure; treat ~$6.88/2.6% as the likely current run-rate pending confirmation at the next payment date.
  • Dividend CAGR: ~11.2%/yr over 9 years (2016→2025), ~11.6%/yr over 10 years, but only ~7.1%/yr over the last 5 years — the raise cadence has decelerated, consistent with the top-line deceleration above. Still comfortably ahead of inflation and well above the framework's bar for a "growing, not just paying" name.
  • Payout ratio: 58.2% (FY2025, roic.ai) vs. 48.6% (FY2024) — the jump looks concerning in isolation but is mostly the FY2024 divestiture-gain artifact flagged in §0, not a genuine deterioration in coverage.
  • FCF payout ratio: ~66% ($1.785B dividends ÷ $2.707B FCF, FY2025) — comfortably covered, with real headroom before the dividend itself would be at any risk, even though the combined dividend+buyback program has been running ahead of FCF (see capital allocation above — that's a buyback-discipline question, not a dividend-safety one).
  • DYT read: current yield sits modestly above its 5yr average (2.26%) — and unlike XYL/PNR, this is not a price-driven false signal (pitfall-dyt-inverts-when-price-caused-the-yield doesn't fire here) since the stock is only 12.5% off its 52-week high. This is a genuine, if mild, "cheap relative to own dividend history" signal.

Verdict on the overlay: passes cleanly. This is a real, uncontested dividend grower — the questions on this name live in valuation and growth-rate, not in dividend safety or streak integrity.

3. Moat & Competitive Advantage

Quantitative base: ROIC 26.9% (FY2025), down modestly from 29.1% (FY2024) but still elite for an industrial — well above XYL (7.3%) and PNR (13.4%), the sleeve's other recent adds. Gross margin 44.1%, essentially flat. This is the quantitative confirmation of a real moat, not a story being told about one.

Revenue-stream map: Seven segments — Automotive OEM (fasteners/components, ~flat organically, Europe -5%), Food Equipment (flat, service +5% offsetting equipment -2%), Test & Measurement/Electronics (+10%), Welding (+14%, the standout), Polymers & Fluids (+7%), plus Construction Products and Specialty Products. No single segment is more than roughly a sixth of revenue — genuine diversification, not a single-product story wearing a diversified label.

Adversarial stress-test — "how would a well-funded rival attack this?" Each segment's moat source differs: engineered-fastener and food-equipment specification-in (certifications, embedded OEM/dealer specs) create real switching costs; the Welding brand (Miller Electric) and Food Equipment brands (Hobart, Vulcan) carry genuine brand equity with contractors and restaurant operators who don't want to re-certify or retrain on a new line. The weakest point is Automotive OEM — flat growth with a -5% Europe print reflects genuine cyclical/content-per-vehicle exposure (EV transition, China auto-market softness) that a scaled Tier-1 competitor or a China-based auto-parts supplier could contest on price in commoditized fastener/component lines. None of the seven segments face an obvious technological disruption vector — these are mature, mechanical, engineered-component categories, not software-displaceable ones.

Disruption forecast: The live threats are cyclical and geopolitical, not technological — tariff/input-cost exposure (steel, aluminum, China-sourced components directly named in the segments most affected: welding equipment, construction products, automotive components), FX volatility, and a slower-than-hoped China industrial/auto recovery. No credible 5-10yr disruption vector displaces engineered fasteners, welding equipment, or commercial food equipment outright.

Evergreen assessment: High. The diversification itself is the evergreen case — a 63-year unbroken dividend record spanning 2008-09 and 2020 is empirical proof the business model survives full cycles without a single end-market collapse sinking the whole company. This is a "forever" business in the sense that matters: no segment failure is company-ending.

Moat defense: the 80/20 model itself is management's standing answer to margin/moat erosion — continuous SKU and customer rationalization toward the highest-value 20% is a genuinely disciplined, repeatable process rather than a one-time initiative, and the margin stability above is the evidence it's working.

4. Valuation

Applied conditionally — ITW is a mature, high-ROIC dividend grower with genuine book value complications (buyback-shrunk equity, the mirror image of PNR/XYL's goodwill-inflated book), so the multiple-based read carries the most weight, with Graham weighted near-zero and DDM/DYT/Bogle as supporting context.

Model Inputs Output
Graham IV √(22.5 × EPS(ttm) $11.03 × BVPS $10.16) $50.22 — essentially uninformative here. Book value is artificially tiny because 15+ years of buybacks have shrunk equity to $3.23B against a $75B+ market cap; Graham's formula assumes book value reflects a real asset base, which it does not for this name. Weight at zero, not as a floor.
Multiple-based (primary) ITW's own FY2026 guide midpoint ($11.45) × a 20-24x band (below ITW's own richer 2024-25 trading multiples, but appropriate given the confirmed growth deceleration StockStory flags) Fair value $229-$275. Spot ($265.20) implies 23.16x the guide — near the top of this band, not the bottom.
Bogle Expected Return Yield ~2.4-2.6% + management's underlying algorithm (~4% organic growth + margin discipline + ~2%/yr buyback accretion ≈ 7-8% EPS growth), flat multiple ~9.5-10.5%/yr with no re-rating. If the multiple compresses toward the 20x floor (plausible given the sell-side split below), total return falls to mid-single-digits; a re-rating toward 24-26x would push it into the low-to-mid teens.
DYT Current yield modestly above 5yr avg (2.26%) Mild, genuine positive — not price-crash-driven (see §2). Supportive, not decisive on its own.
DDM Gordon growth, D1≈$6.89 (assuming the ~7% raise confirms), r≈9% (10yr ~4.2% + beta 1.00×5% ERP) g=6%: ~$230; g=7%: ~$345 (extremely sensitive to the r-g spread, as always at these inputs — treat as a sanity-check range, not a point estimate). The g=6% case lines up closely with the multiple-based floor, which is reassuring cross-validation; the g=7% case requires assuming the historical 11%/yr dividend-growth pace resumes, which the last 5 years (7.1%/yr) argue against.

Fair value: $229-275. Current price ($265.20) sits in the upper third of this range — near a 23x forward multiple on ITW's own guide, not at a discount. This is the "Great business, not-yet-cheap price" quadrant from the framework's first-principles table: good company, expensive-enough-to-wait entry.

Entry zone: $230-245 (roughly 20.1-21.4x the FY26 guide) — this is close to the stock's own 52-week low ($238.82), meaning the market has already tested this zone once this year; it's not a hypothetical discount, it's a level that has recently traded. Trim: 24x fwd (~$275 today on the current guide, rising as the FY26/27 guide updates) — deliberately at the top of the band above, since StockStory's growth-deceleration case argues against ITW earning a re-rating premium past its own recent historical range right now.

5. Sentiment

Q2 FY2026 (reported Jul 28-29, 2026) was a clean beat-and-raise. Organic growth +4.5%, record quarterly operating income ($1.15B), GAAP EPS $2.84 (+10% YoY), and full-year guidance raised on both lines (organic midpoint 3.5%, EPS midpoint $11.45). Segment strength is capex-linked and broad-based (Welding +14%, Test & Measurement/Electronics +10%, Polymers & Fluids +7%); the only soft spots are Automotive OEM (flat, Europe -5%) and Food Equipment (flat, equipment -2% offset by service +5%) — both read as demand-mix issues in specific sub-markets, not company-wide softness.

Sell-side is genuinely split — a real tension, not noise to average away. Of the 7 rating actions in the last ~6 months, 3 carry Underweight/Underperform ratings (Evercore ISI, Wells Fargo, Barclays) even as every single action in the period raised its price target (Evercore $272→$309, JPM $310→$350, Baird $278→$297, Truist $280→$301, Wells Fargo $245→$255, Citi $284→$287; only Barclays cut, $275→$250). The pattern reads as "better business than we feared, still too expensive to upgrade" — sell-side is validating the fundamentals while withholding conviction on valuation, which lines up almost exactly with this report's own multiple-based read (fair value near spot, not below it). Mean target ~$302 (per fin.py) sits ~14% above spot, but the rating mix underneath that average is more cautious than the average alone suggests.

Insider activity: mixed, mildly constructive. The large-dollar Form 4s (Santi, Larsen, O'Herlihy, Lawler, Beck, Scheuneman selling $1M-$49M in various 2025-2026 transactions) are overwhelmingly option-exercise-and-sell compensation mechanics, not conviction signals (pitfall-yahoo-insider-purchases-counts-rsu-grants-adjacent — these are exercises, not fresh capital commitments either way). Underneath that noise are a handful of genuine, small open-market purchases by directors: David Byron Smith Jr. bought at $250.13 (Dec 2025), $241.16 (Jun 2025), and $275.20 (Dec 2024); Jennifer Scanlon bought at $247.99 (Jun 2026). These are modest-dollar buys ($175K-$1.7M range) but real cash commitments at prices spanning the current entry zone — a small golden flag, not a decisive one.

StockStory's skepticism is a legitimate, verified bear case, not a throwaway line — the 2-year revenue CAGR (1.4%) and "only 4%/yr" historical EPS growth are real numbers that argue this is a premium multiple on a business that has genuinely slowed, even after crediting the Q2 re-acceleration. Tariff/FX/China-auto-recovery risk is the named macro overhang across multiple sources — steel/aluminum input costs and China-sourced component tariffs hit Welding, Construction Products, and Automotive OEM specifically, the same segments already showing the most mixed results.

6. Synthesis — Weighted Verdict

Per the framework's conflict-resolution rule, for a mature, high-ROIC dividend-growing industrial, Fundamentals + Valuation carry the most weight, with Moat and Sentiment as important context.

Fundamentals + Moat say: this is an excellent business — 63-year unbroken dividend record, 26-29% ROIC, 44% gross margins, genuine multi-segment diversification with no single-point-of-failure end market, and a Q2 print that beat and raised guidance on real organic strength (Welding +14%, T&M +10%). The 80/20 operating discipline shows up directly in stable elite margins, not just in the pitch deck.

Valuation says: not there yet. The multiple-based fair value ($229-275) brackets spot ($265.20) but places it in the upper third, at roughly 23x the company's own guide — a genuine, not cheap, price for a business whose 2-year growth rate (StockStory's 1.4%) has been real and its raise cadence has slowed (11%/yr dividend growth a decade ago, ~7%/yr now). Graham is uninformative here (buyback-shrunk book value), and DDM's more credible scenario (g=6%, ~$230) sits right at the entry zone rather than above spot — a second, independent signal that spot is full, not cheap.

Sentiment supplies the clearest tension worth naming, not burying: sell-side is simultaneously raising numbers and refusing to upgrade — three Underweight/Underperform ratings sit alongside price-target hikes on every single recent action. That is not confusion; it is the market pricing the same "quality business, full valuation" read this report reaches independently.

Verdict: WATCH, conviction 6.0/10. ITW is a legitimate, durable addition to the sleeve's roster on quality grounds — but the current price sits in the expensive third of a defensible fair-value range, not in a buy zone. This is the "Great + Expensive → Wait" quadrant from the framework's own first-principles table, not a "Great + Cheap" value case.

Answering the brief's explicit questions

  1. §1 health bar: Passes cleanly — elite, stable margins (44% gross / 26%+ operating), 26-29% ROIC, real per-share buyback tailwind (-2%/yr share count), and a genuinely well-covered dividend. The one real fundamentals flag is capital-allocation, not earnings quality: buybacks+dividends have modestly exceeded FCF for two straight years, bridged by rising short-term debt.
  2. Buy zone or watch: Watch. Spot ($265.20) sits above the $230-245 entry zone (roughly 20-21x guide) and near the top of the $229-275 fair-value band (~23x guide). The stock's own 52-week low ($238.82) already sits inside the entry zone, so this isn't a hypothetical level — it traded there within the last year.
  3. Beats ZTS/HLNE (5.5)? Diversify or overlap vs EMR/ETN? Yes on both. ITW clears ZTS/HLNE's 5.5 floor — it carries none of ZTS's guidance-cut/organic-decline problem or HLNE's contested non-GAAP-definition-change discount; its dividend and earnings-quality picture are clean by comparison, even if growth is unexciting. On the concentration-map question: ITW genuinely diversifies the sleeve away from EMR and ETN, both of which are now substantially levered to the AI-data-center power/automation capex cycle (EMR's automation/software platform, ETN's grid-to-chip electrification backlog). ITW's growth drivers — auto-build rates, restaurant capex, general industrial welding/fastener demand — share essentially no AI-capex dependency with EMR/ETN, so owning it alongside them is a real diversification, not a third slice of the same bet.
  4. Proposed conviction: 6.0. Above ZTS/HLNE (5.5) on quality and cleanliness of the dividend/earnings picture; below XYL (6.5)/PNR (6.0-tied) because those two are actually inside their entry zones today, and well below EMR (7.5)/ETN (7.0) because ITW lacks a comparable near-term growth catalyst. Revisit at the Oct 27, 2026 Q3 print — confirm the dividend raise dollar figure, check whether Automotive OEM's Europe softness is stabilizing or widening, and re-derive the entry zone off the next guidance update.

Key risks (named, not buried)

  1. Valuation is the whole case against buying today. Every value-sensitive model (multiple-based, DDM at a credible growth rate) places fair value at or below spot — this is priced for continued execution, not for error.
  2. Growth deceleration is real, independently verified (StockStory's 1.4% 2yr CAGR), and only partially answered by one strong quarter. A second consecutive soft print would revive the bear case with more force than the Q2 beat currently resolves.
  3. Capital allocation has run ahead of FCF for two straight years. Not a crisis at 1.76x net debt/EBITDA today, but a trend that would matter if FCF weakens further while the $1.50B/yr buyback pace continues unchanged.
  4. Automotive OEM / tariff / China exposure is the one segment-and-macro combination already showing cracks (Europe -5%) and carrying the most named external risk (steel/aluminum tariffs, China-sourced components, a slower China auto recovery) — worth tracking as the "canary" segment for the next 1-2 prints.

Data Gaps / Caveats

  • roic.ai (free tier) returned only 2 years of annual history (2024-2025) — the framework's preferred 5-8yr FCF/ROIC trend isn't fully derivable from the tools on hand; fin.py's 4-year window (2022-2025) is the deepest available without a dedicated web/10-K pull for 2018-2021 figures.
  • The exact current quarterly dividend dollar amount is not fully reconciled — raw payment-history data confirms $1.61/qtr through Jun-2026; multiple 2026 news sources describe a ~7% raise cycle that fin.py's cached yield field is partially consistent with (implying ~$1.72-1.73/qtr) but the payment-history feed has not caught up. Treat $6.44/2.43% as the confirmed floor, ~$6.88/2.6% as the likely (not yet confirmed) current run-rate.
  • DDM output is highly sensitive to the assumed growth rate at these discount-rate levels — treated as a sanity-check range, not a precise anchor, consistent with how XYL and PNR's reports handled the same model.